Immunome, Inc. - Common Stock (IMNM)
11.83
+0.75 (6.77%)
Immunome Inc is a biopharmaceutical company focused on developing innovative antibody therapies for the treatment of cancer and other diseases
The company leverages its proprietary platform to identify and isolate antibodies from human immune cells, which are then engineered to target specific antigens linked to various diseases. By harnessing the body's natural immune response, Immunome aims to create therapies that are both effective and safe, with a commitment to improving patient outcomes in oncology and beyond. Through its research and development efforts, Immunome is dedicated to advancing the field of immunotherapy and addressing unmet medical needs.
Frequently Asked Questions
Is Immunome, Inc. - Common Stock publicly traded?
Yes, Immunome, Inc. - Common Stock is publicly traded.
What exchange does Immunome, Inc. - Common Stock trade on?
Immunome, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immunome, Inc. - Common Stock?
The ticker symbol for Immunome, Inc. - Common Stock is IMNM on the Nasdaq Stock Market
What is the current price of Immunome, Inc. - Common Stock?
The current price of Immunome, Inc. - Common Stock is 11.83
When was Immunome, Inc. - Common Stock last traded?
The last trade of Immunome, Inc. - Common Stock was at 4:00 pm EST on February 5th, 2025
What is the market capitalization of Immunome, Inc. - Common Stock?
The market capitalization of Immunome, Inc. - Common Stock is 738.39M
How many shares of Immunome, Inc. - Common Stock are outstanding?
Immunome, Inc. - Common Stock has 62.42M shares outstanding.